4/A
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-023327
Chief Executive Officer sold 200 shares at $38.40 ($7,680)
From the SEC's structured data for this filing
Atara Biotherapeutics, Inc. Filed Acc 0001209191-18-023327
Chief Executive Officer sold 200 shares at $38.40 ($7,680)
From the SEC's structured data for this filing
Connection lost
Reconnecting…
Cite Filings isn't responding
Reconnecting…